2010•Chinese Journal of Clinical Rational Drug UseRequires access

Drug resistance analysis on E.coli and K.pneumoniae produced extended spectrum β-lactamases

Dai Ying-yin

Open publisher page 0 citations

Abstract

Objective To investigate the resistance and distributing situation of extended-spectrum β-lactamases (ESBLs)-producing strains in E.coli and K.pneumoniae in our hospital during last year,so as to guide the clinical drug use.Methods 396 strains of E.coli and K.pneumoniae were detected and analyzed by K-B agar diffusion method and confirmed test.Results The positive rate of ESBLs-producing among E.coli and K.pneumoniae was 52.7% and 35.7%,respectively. ESBLs had lower drug resistant rate to imipenem,piperacillin/sulbactam,cefoxitin and amikacin.Conclusion It is very important to pay attention to the determination of ESBLs-producing strains.We should reasonably use drug according to the result of susceptibility test.The ideal antibacterial drugs for treating ESBLs-producing bacteria are carbapenems,cefoxitin,complex antibiotics containing β-lactamases inhibitor and amikacin.

About this research paper

What this paper is about

Objective To investigate the resistance and distributing situation of extended-spectrum β-lactamases (ESBLs)-producing strains in E.coli and K.pneumoniae in our hospital during last year,so as to guide the clinical drug use.Methods 396 strains of E.coli and K.pneumoniae were detected and analyzed by K-B agar diffusion method and confirmed test.Results The positive rate of ESBLs-producing among E.coli and K.pneumoniae was 52.7% and 35.7%,respectively. ESBLs had lower drug resistant rate to imipenem,piperacillin/sulbactam,cefoxitin and amikacin.Conclusion It is very important to pay attention to the determination of ESBLs-producing strains.We should reasonably use drug according to the result of susceptibility test.The ideal antibacterial drugs for treating ESBLs-producing bacteria are carbapenems,cefoxitin,complex antibiotics containing β-lactamases inhibitor and amikacin.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the resistance and distributing situation of extended-spectrum β-lactamases (ESBLs)-producing strains in E.coli and K.pneumoniae in our hospital during last year,so as to guide the clinical drug use.Methods 396 strains of E.coli and K.pneumoniae were detected and analyzed by K-B agar diffusion method and confirmed test.Results The positive rate of ESBLs-producing among E.coli and K.pneumoniae was 52.7% and 35.7%,respectively. ESBLs had lower drug resistant rate to imipenem,piperacillin/sulbactam,cefoxitin and amikacin.Conclusion It is very important to pay attention to the determination of ESBLs-producing strains.We should reasonably use drug according to the result of susceptibility test.The ideal antibacterial drugs for treating ESBLs-producing bacteria are carbapenems,cefoxitin,complex antibiotics containing β-lactamases inhibitor and amikacin.

Key concepts: Cefoxitin, Amikacin, Imipenem, Sulbactam, Medicine, Piperacillin, Microbiology, Drug resistance

Related papers

Back to paper searchBrowse research topicsOriginal source
Drug resistance analysis on E.coli and K.pneumoniae produced extended spectrum β-lactamases — Research Paper | ScholarLens